Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367378 · ClinicalTrials.gov registry record
Minimally Invasive Surgery (MIS) for Spine Metastases
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 14
- Enrollment target
NCT02367378: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02367378 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02367378 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information on the effect of minimally invasive spine tumor decompression on treated patients. This treatment option is less invasive that the standard surgical decompression and is expected to result in better wound healing, decreased tissue trauma, and decreased pain after surgery.
Primary Outcome
Survival time in days
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-06-13 |
What the finished NCT02367378 record still lists
NCT02367378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02367378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02367378 about?
NCT02367378 is a clinical study titled "Minimally Invasive Surgery (MIS) for Spine Metastases". The purpose of this study is to collect information on the effect of minimally invasive spine tumor decompression on treated patients. This treatment option is less invasive that the standard surgical decompression and is expected to result in better wound healing, decreased tissue trauma, and decre...
What is the current status of trial NCT02367378?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2015-02. Estimated completion is 2016-06-13.
Who is sponsoring clinical trial NCT02367378?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia